Hyaluronic Acid Shows Promise as Neuropathic Pain Treatment
Cross-linked hyaluronic acid (HA) injections reduced Visual Analog Scale of Pain (VAS) scores in patients with neuropathic pain.
All articles by Nicole Blazek
NIH Requests Budget Add-On to Combat Alzheimer’s and Dementia
The Bypass Budget proposes $323,355 in additional resources above the current baseline appropriations for fiscal year 2017.
Type 1 Diabetes Patients Very Likely to Develop Dementia
Those with type 1 diabetes were 61% more likely to develop dementia after adjustments.
AVP-923 Significantly Reduces Agitation in Alzheimer’s Disease
Phase-2 study results suggest AVP-923 has meaningful effects in reducing agitation.
Amyloid PET Scans May Inform Dementia Treatments
Clinical trials are underway to evaluate if access to amyloid PET scans affects treatment decisions in dementia.
Cognitive Impairment Progresses More Rapidly in Women
Differences in brain structure, disease progression and biological characteristics may play a role.
Academic Performance in Childhood Predicts Dementia Risk
Early academic performance may better indicate cognitive reserve than formal education and occupational complexity.
Cancer ‘Neuroinvasion’ Plays Role in Cancer Pain, Progression
In addition to contributing significantly to cancer pain, researchers believe cancer progression depends largely on nerve activity.
Medical Marijuana for Pain: Many Questions Remain
About 15 trials of medical cannibinoids have been conducted worldwide, indicating effectiveness in reducing pain from cancer, diabetes, fibromyalgia, and neuropathy
High-Dose Biotin Drug Improves Progressive Multiple Sclerosis Symptoms
Investigational multiple sclerosis drug MD1003 delivers 300 mg/day of biotin, a huge increase the usually recommended dose of 30-100 mcg/day.
-
Loading...
-
Loading...
Next post in AAN 2015 Coverage
